nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.333	0.426	CbGaD
Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.254	0.325	CbGaD
Clomipramine—HTR2A—attention deficit hyperactivity disorder	0.195	0.25	CbGaD
Clomipramine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00868	0.137	CbGeAlD
Clomipramine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00522	0.0825	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00461	0.073	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00277	0.0438	CbGeAlD
Clomipramine—HTR6—forebrain—attention deficit hyperactivity disorder	0.00223	0.0353	CbGeAlD
Clomipramine—HRH2—cardiovascular system—attention deficit hyperactivity disorder	0.00172	0.0273	CbGeAlD
Clomipramine—GSTP1—forebrain—attention deficit hyperactivity disorder	0.00147	0.0232	CbGeAlD
Clomipramine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00129	0.0204	CbGeAlD
Clomipramine—GSTP1—cardiovascular system—attention deficit hyperactivity disorder	0.00124	0.0196	CbGeAlD
Clomipramine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00122	0.0193	CbGeAlD
Clomipramine—HTR6—nervous system—attention deficit hyperactivity disorder	0.00121	0.0191	CbGeAlD
Clomipramine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00121	0.0191	CbGeAlD
Clomipramine—HTR6—central nervous system—attention deficit hyperactivity disorder	0.00116	0.0184	CbGeAlD
Clomipramine—HRH2—nervous system—attention deficit hyperactivity disorder	0.00111	0.0175	CbGeAlD
Clomipramine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00107	0.017	CbGeAlD
Clomipramine—HRH2—central nervous system—attention deficit hyperactivity disorder	0.00106	0.0168	CbGeAlD
Clomipramine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00102	0.0162	CbGeAlD
Clomipramine—GSTP1—midbrain—attention deficit hyperactivity disorder	0.000969	0.0153	CbGeAlD
Clomipramine—HTR6—brain—attention deficit hyperactivity disorder	0.000925	0.0146	CbGeAlD
Clomipramine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00085	0.0135	CbGeAlD
Clomipramine—HRH2—brain—attention deficit hyperactivity disorder	0.000845	0.0134	CbGeAlD
Clomipramine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000806	0.0128	CbGeAlD
Clomipramine—GSTP1—nervous system—attention deficit hyperactivity disorder	0.000796	0.0126	CbGeAlD
Clomipramine—GSTP1—central nervous system—attention deficit hyperactivity disorder	0.000767	0.0121	CbGeAlD
Clomipramine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.00076	0.012	CbGeAlD
Clomipramine—GSTP1—cerebellum—attention deficit hyperactivity disorder	0.000749	0.0119	CbGeAlD
Clomipramine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000699	0.0111	CbGeAlD
Clomipramine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000673	0.0106	CbGeAlD
Clomipramine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000663	0.0105	CbGeAlD
Clomipramine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000657	0.0104	CbGeAlD
Clomipramine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000646	0.0102	CbGeAlD
Clomipramine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000638	0.0101	CbGeAlD
Clomipramine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000632	0.01	CbGeAlD
Clomipramine—GSTP1—brain—attention deficit hyperactivity disorder	0.000609	0.00963	CbGeAlD
Clomipramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000589	0.00931	CbGeAlD
Clomipramine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000583	0.00923	CbGeAlD
Clomipramine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000562	0.00889	CbGeAlD
Clomipramine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000546	0.00864	CbGeAlD
Clomipramine—HTR2C—brain—attention deficit hyperactivity disorder	0.000534	0.00845	CbGeAlD
Clomipramine—ALB—brain—attention deficit hyperactivity disorder	0.000521	0.00825	CbGeAlD
Clomipramine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000507	0.00801	CbGeAlD
Clomipramine—HTR2B—brain—attention deficit hyperactivity disorder	0.000502	0.00794	CbGeAlD
Clomipramine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000502	0.00794	CbGeAlD
Clomipramine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000446	0.00705	CbGeAlD
Clomipramine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000427	0.00675	CbGeAlD
Clomipramine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000423	0.0067	CbGeAlD
Clomipramine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000412	0.00652	CbGeAlD
Clomipramine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000397	0.00628	CbGeAlD
Clomipramine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000388	0.00614	CbGeAlD
Clomipramine—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.000364	0.04	CrCbGaD
Clomipramine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000358	0.00566	CbGeAlD
Clomipramine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000351	0.00555	CbGeAlD
Clomipramine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000338	0.00534	CbGeAlD
Clomipramine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.00033	0.00522	CbGeAlD
Clomipramine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000325	0.00514	CbGeAlD
Clomipramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000319	0.00505	CbGeAlD
Clomipramine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000315	0.00499	CbGeAlD
Clomipramine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000313	0.00494	CbGeAlD
Clomipramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000308	0.00487	CbGeAlD
Clomipramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000301	0.00476	CbGeAlD
Clomipramine—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.000289	0.0318	CrCbGaD
Clomipramine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00028	0.00442	CbGeAlD
Clomipramine—HTR2A—brain—attention deficit hyperactivity disorder	0.000268	0.00424	CbGeAlD
Clomipramine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000249	0.0274	CrCbGaD
Clomipramine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000245	0.027	CrCbGaD
Clomipramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000244	0.00386	CbGeAlD
Clomipramine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000235	0.0258	CrCbGaD
Clomipramine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00023	0.00364	CbGeAlD
Clomipramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000229	0.0252	CrCbGaD
Clomipramine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000228	0.0251	CrCbGaD
Clomipramine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000221	0.0035	CbGeAlD
Clomipramine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000216	0.00342	CbGeAlD
Clomipramine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00019	0.0209	CrCbGaD
Clomipramine—ABCB1—brain—attention deficit hyperactivity disorder	0.000176	0.00278	CbGeAlD
Clomipramine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.00017	0.0187	CrCbGaD
Clomipramine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000158	0.0173	CrCbGaD
Clomipramine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000154	0.017	CrCbGaD
Clomipramine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000152	0.0167	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.000151	0.0166	CrCbGaD
Clomipramine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000149	0.0164	CrCbGaD
Clomipramine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000148	0.0162	CrCbGaD
Clomipramine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000134	0.0147	CrCbGaD
Clomipramine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000127	0.014	CrCbGaD
Clomipramine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000126	0.0139	CrCbGaD
Clomipramine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000122	0.0134	CrCbGaD
Clomipramine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.00012	0.0132	CrCbGaD
Clomipramine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000119	0.0131	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.000113	0.0124	CrCbGaD
Clomipramine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.000113	0.0124	CrCbGaD
Clomipramine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000111	0.0122	CrCbGaD
Clomipramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00011	0.0121	CrCbGaD
Clomipramine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.00011	0.0121	CrCbGaD
Clomipramine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000109	0.012	CrCbGaD
Clomipramine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000108	0.0119	CrCbGaD
Clomipramine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.000107	0.0118	CrCbGaD
Clomipramine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.0115	CrCbGaD
Clomipramine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000105	0.0115	CrCbGaD
Clomipramine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.000104	0.0114	CrCbGaD
Clomipramine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.0113	CrCbGaD
Clomipramine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000102	0.0112	CrCbGaD
Clomipramine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.011	CrCbGaD
Clomipramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	9.77e-05	0.0107	CrCbGaD
Clomipramine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	9.71e-05	0.0107	CrCbGaD
Clomipramine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	9.63e-05	0.0106	CrCbGaD
Clomipramine—Promazine—DRD1—attention deficit hyperactivity disorder	9.34e-05	0.0103	CrCbGaD
Clomipramine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	9.14e-05	0.0101	CrCbGaD
Clomipramine—Propiomazine—DRD2—attention deficit hyperactivity disorder	8.89e-05	0.00978	CrCbGaD
Clomipramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	8.68e-05	0.00955	CrCbGaD
Clomipramine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	8.59e-05	0.00945	CrCbGaD
Clomipramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	8.53e-05	0.00938	CrCbGaD
Clomipramine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	8.41e-05	0.00926	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	8.4e-05	0.00924	CrCbGaD
Clomipramine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	8.38e-05	0.00921	CrCbGaD
Clomipramine—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	8.3e-05	0.00913	CrCbGaD
Clomipramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	8.28e-05	0.00911	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	8.26e-05	0.00909	CrCbGaD
Clomipramine—Nortriptyline—DRD2—attention deficit hyperactivity disorder	8.26e-05	0.00908	CrCbGaD
Clomipramine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	8.22e-05	0.00904	CrCbGaD
Clomipramine—Thioridazine—DRD2—attention deficit hyperactivity disorder	7.96e-05	0.00876	CrCbGaD
Clomipramine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	7.82e-05	0.0086	CrCbGaD
Clomipramine—Trimipramine—DRD2—attention deficit hyperactivity disorder	7.78e-05	0.00855	CrCbGaD
Clomipramine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	7.75e-05	0.00853	CrCbGaD
Clomipramine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	7.64e-05	0.0084	CrCbGaD
Clomipramine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	7.6e-05	0.00836	CrCbGaD
Clomipramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	7.55e-05	0.00831	CrCbGaD
Clomipramine—Promethazine—DRD2—attention deficit hyperactivity disorder	7.49e-05	0.00824	CrCbGaD
Clomipramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	7.45e-05	0.0082	CrCbGaD
Clomipramine—Doxepin—DRD2—attention deficit hyperactivity disorder	7.41e-05	0.00815	CrCbGaD
Clomipramine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	7.39e-05	0.00813	CrCbGaD
Clomipramine—Perphenazine—DRD2—attention deficit hyperactivity disorder	7.31e-05	0.00804	CrCbGaD
Clomipramine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	6.87e-05	0.00756	CrCbGaD
Clomipramine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	6.84e-05	0.00752	CrCbGaD
Clomipramine—Desipramine—DRD2—attention deficit hyperactivity disorder	6.8e-05	0.00748	CrCbGaD
Clomipramine—Promazine—DRD2—attention deficit hyperactivity disorder	6.59e-05	0.00725	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	6.5e-05	0.00715	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	6.38e-05	0.00702	CrCbGaD
Clomipramine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	6.15e-05	0.00677	CrCbGaD
Clomipramine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	6.01e-05	0.00661	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	5.87e-05	0.00646	CrCbGaD
Clomipramine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	5.8e-05	0.00638	CrCbGaD
Clomipramine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	5.8e-05	0.00638	CrCbGaD
Clomipramine—Promethazine—HTR2A—attention deficit hyperactivity disorder	5.79e-05	0.00636	CrCbGaD
Clomipramine—Imipramine—DRD2—attention deficit hyperactivity disorder	5.77e-05	0.00634	CrCbGaD
Clomipramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	5.76e-05	0.00634	CrCbGaD
Clomipramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	5.73e-05	0.0063	CrCbGaD
Clomipramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	5.73e-05	0.0063	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	5.71e-05	0.00628	CrCbGaD
Clomipramine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	5.65e-05	0.00621	CrCbGaD
Clomipramine—Desipramine—HTR2A—attention deficit hyperactivity disorder	5.25e-05	0.00578	CrCbGaD
Clomipramine—Promazine—HTR2A—attention deficit hyperactivity disorder	5.09e-05	0.0056	CrCbGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.9e-05	0.000337	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.9e-05	0.000337	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.89e-05	0.000336	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.89e-05	0.000336	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.84e-05	0.000333	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	4.78e-05	0.000329	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.75e-05	0.000326	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.73e-05	0.000325	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.7e-05	0.000323	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.7e-05	0.000323	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.66e-05	0.00032	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.64e-05	0.000319	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.61e-05	0.000317	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.6e-05	0.000316	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.6e-05	0.000316	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.59e-05	0.000316	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.55e-05	0.000312	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.52e-05	0.000311	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.52e-05	0.00031	CbGpPWpGaD
Clomipramine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	4.48e-05	0.00493	CrCbGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.46e-05	0.000307	CbGpPWpGaD
Clomipramine—Imipramine—HTR2A—attention deficit hyperactivity disorder	4.46e-05	0.0049	CrCbGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.45e-05	0.000306	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.43e-05	0.000305	CbGpPWpGaD
Clomipramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	4.43e-05	0.00487	CrCbGaD
Clomipramine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.4e-05	0.000302	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.33e-05	0.000298	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.33e-05	0.000298	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.31e-05	0.000296	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.3e-05	0.000296	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.3e-05	0.000296	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.28e-05	0.000294	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.27e-05	0.000294	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.23e-05	0.000291	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.21e-05	0.000289	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.2e-05	0.000288	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.17e-05	0.000287	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.16e-05	0.000286	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.13e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.12e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.1e-05	0.000282	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.09e-05	0.000281	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.07e-05	0.00028	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.05e-05	0.000278	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.05e-05	0.000278	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—COMT—attention deficit hyperactivity disorder	4.03e-05	0.000277	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—MAOA—attention deficit hyperactivity disorder	4e-05	0.000275	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4e-05	0.000275	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4e-05	0.000275	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.96e-05	0.000272	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.00027	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.93e-05	0.00027	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000268	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.81e-05	0.000262	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.8e-05	0.000261	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.8e-05	0.000261	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.79e-05	0.000261	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.78e-05	0.000259	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.76e-05	0.000258	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.75e-05	0.000257	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.74e-05	0.000257	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.7e-05	0.000254	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.57e-05	0.000245	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.00024	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.45e-05	0.000237	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.45e-05	0.000237	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.43e-05	0.000236	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.41e-05	0.000235	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.4e-05	0.000233	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.4e-05	0.000233	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.35e-05	0.00023	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.32e-05	0.000228	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.32e-05	0.000228	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.3e-05	0.000227	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000226	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	3.28e-05	0.000226	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.27e-05	0.000224	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.27e-05	0.000224	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.22e-05	0.000221	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.21e-05	0.000221	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.17e-05	0.000218	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.16e-05	0.000217	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.13e-05	0.000215	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.13e-05	0.000215	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.12e-05	0.000214	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.09e-05	0.000212	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.07e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.06e-05	0.00021	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.04e-05	0.000209	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3e-05	0.000206	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.98e-05	0.000205	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.97e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.97e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.95e-05	0.000203	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.94e-05	0.000202	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.91e-05	0.0002	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.91e-05	0.0002	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.89e-05	0.000199	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.89e-05	0.000199	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.86e-05	0.000196	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.85e-05	0.000196	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.84e-05	0.000195	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.78e-05	0.000191	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.76e-05	0.00019	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.76e-05	0.000189	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.74e-05	0.000188	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.7e-05	0.000185	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.68e-05	0.000184	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.67e-05	0.000184	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.67e-05	0.000183	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.66e-05	0.000183	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.66e-05	0.000183	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.66e-05	0.000183	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.64e-05	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.63e-05	0.000181	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.62e-05	0.00018	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.6e-05	0.000178	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.59e-05	0.000178	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.58e-05	0.000177	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.55e-05	0.000175	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.53e-05	0.000174	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.51e-05	0.000172	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.5e-05	0.000172	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.47e-05	0.000169	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.43e-05	0.000167	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.42e-05	0.000167	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.42e-05	0.000166	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.41e-05	0.000166	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.41e-05	0.000166	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.39e-05	0.000164	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.36e-05	0.000162	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.33e-05	0.00016	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.32e-05	0.00016	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.31e-05	0.000159	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.27e-05	0.000156	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.25e-05	0.000155	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.23e-05	0.000153	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.22e-05	0.000152	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.22e-05	0.000152	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.21e-05	0.000152	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.2e-05	0.000151	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.19e-05	0.00015	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.18e-05	0.00015	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.14e-05	0.000147	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.14e-05	0.000147	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.09e-05	0.000144	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.04e-05	0.00014	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.04e-05	0.00014	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.03e-05	0.000139	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2e-05	0.000138	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000129	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.82e-05	0.000125	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000125	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.77e-05	0.000122	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.77e-05	0.000122	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000121	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.75e-05	0.00012	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	1.75e-05	0.00012	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.75e-05	0.00012	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—EP300—attention deficit hyperactivity disorder	1.73e-05	0.000119	CbGpPWpGaD
Clomipramine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.72e-05	0.000118	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.69e-05	0.000116	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000113	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.63e-05	0.000112	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.6e-05	0.00011	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.59e-05	0.000109	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.58e-05	0.000108	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.57e-05	0.000108	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.57e-05	0.000108	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.56e-05	0.000107	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.55e-05	0.000106	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.54e-05	0.000106	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.54e-05	0.000106	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.53e-05	0.000105	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.53e-05	0.000105	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.53e-05	0.000105	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.51e-05	0.000104	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.48e-05	0.000102	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.44e-05	9.92e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.44e-05	9.92e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.44e-05	9.86e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.43e-05	9.86e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.43e-05	9.8e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.43e-05	9.79e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.42e-05	9.76e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.42e-05	9.76e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.4e-05	9.63e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.4e-05	9.61e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.39e-05	9.57e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.37e-05	9.4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.34e-05	9.22e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.33e-05	9.16e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	9.14e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.32e-05	9.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.3e-05	8.91e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.26e-05	8.62e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.23e-05	8.42e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.22e-05	8.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.22e-05	8.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.2e-05	8.27e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.19e-05	8.21e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.17e-05	8.01e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.15e-05	7.93e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.9e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.12e-05	7.7e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.12e-05	7.69e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.1e-05	7.55e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.08e-05	7.41e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.06e-05	7.28e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.05e-05	7.23e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.02e-05	7.01e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.78e-06	6.72e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	9.51e-06	6.53e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	9.45e-06	6.49e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	9.44e-06	6.49e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.44e-06	6.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.31e-06	6.4e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	9.29e-06	6.38e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.29e-06	6.38e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.22e-06	6.33e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.16e-06	6.29e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.09e-06	6.24e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.75e-06	6.01e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.69e-06	5.97e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.64e-06	5.93e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.28e-06	5.68e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.55e-06	5.19e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.55e-06	5.19e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	7.41e-06	5.09e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.36e-06	5.06e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.19e-06	4.94e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.14e-06	4.9e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.09e-06	4.19e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	5.76e-06	3.96e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.72e-06	3.93e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.68e-06	3.9e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.29e-06	3.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.82e-06	3.31e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	4.54e-06	3.12e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	4.08e-06	2.8e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.98e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.75e-06	2.58e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.18e-06	2.18e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.45e-06	1.69e-05	CbGpPWpGaD
